Biotech Stock Offers A Buy Point After 256% Average Annual Gain

Krystal Biotech (KRYS) has formed a cup with handle with a buy point of 206.97, according to the daily and weekly charts on IBD MarketSurge. This is a second-stage base-on-base pattern for the biotech stock that could lead to higher gains. Krystal Biotech uses viral vectors to deliver genetic material to different cells to treat conditions such as cystic fibrosis and certain lung diseases. The company received FDA approval for Vyjuvek, its treatment for dystrophic epidermolysis bullosa, a genetic condition affecting the skin, in the second quarter of 2023. It...